3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Topiramate (toe-PYRE-a-mate) is used to help control some types of seizures in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to help control seizures for as long as you continue to take it.


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Neurology -

Increase in variant Creutzfeldt Jakob Disease predicted

NeurologyMar 28, 06

According to the latest research far more people may be at risk of contracting variant Creutzfeldt Jakob Disease (vCJD) than previously thought.

vCJD is the human form of Bovine Spongiform Encephalopathy (BSE), also known as Mad Cow Disease.

Scientists at the Institute for Animal Health in Edinburgh say a long incubation period for the disease, coupled with an ability to pass it on through blood transfusions and surgical instruments, has the potential to create a “significant public health issue”.

By carrying out studies on mice, the team concluded that vCJD could lie in the body for many years without showing any symptoms.

They suspect a “significant level” of underlying vCJD may already be present in the population.

The experts say the incurable brain disease vCJD, the human form of BSE (mad cow disease), may be widespread and advancing undetected as it can be passed from human to human through secondary transmission - such as blood transfusions and contaminated surgical equipment with ease.

The warning raises fears over the safety of blood transfusion and the use of surgical instruments.

vCJD affects the brain and is believed to be passed from cattle to humans through eating meat infected with BSE.

Some people carry the agent but never show symptoms, while others develop the disease after many years.

The study reveals that people may not know they have the agent for vCJD and therefore there is a risk “of further disease transmission”.

To date 161 people in the UK have been victims of the fatal infection which slowly destroys the brain and two of those have been linked to transfusions.

Estimates of the ultimate size of the epidemic have varied from hundreds to thousands of people, but most experts believed that 10 years after the first cases were identified, the numbers would decline.

The warning issued via the new study will pressurise the Government to change the rules on post mortem examinations to include tests for vCJD - which cannot be detected until after death, in order to determine the extent of the epidemic.

A scientific review is currently under way.

The study is published on-line by The Lancet Neurology.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Personal rehab helpful for multiple sclerosis
  Obesity, other health problems delay MS diagnosis
  Physical activity may lessen stroke severity
  Stroke Onset Needs to be Treated Like the Emergency Situation It Is
  Response to immune protein determines pathology of multiple sclerosis
  Occasional Memory Loss Tied to Lower Brain Volume
  Neurotransmitter defect may trigger autoimmune disease
  Nerve Activity Can Predict Life Or Death for Comatose Patients
  New marker for raised intracranial pressure
  Treatment for Parkinson’s examined
  Pain appears common among patients with Parkinson’s disease
  Chronic stress alters our genetic immune response

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site